Armata Pharmaceuticals, Inc.(ARMP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARMP Armata Pharmaceuticals, Inc.

休市中 09-04 16:00:00 EDT

5.84

+0.32

+5.80%

盘后5.84

+0.000.00%

19:30 EDT

最高5.87	最低5.48	成交量4.80万
今开5.49	昨收5.52	日振幅6.97%
总市值2.17亿	流通市值6,935万	总股本3,718万
成交额27.73万	换手率0.40%	流通股本1,188万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARMP","market":"US","secType":"STK","nameCN":"Armata Pharmaceuticals, Inc.","latestPrice":5.84,"timestamp":1788552000000,"preClose":5.52,"halted":0,"volume":48032,"hourTrading":{"tag":"盘后","latestPrice":5.84,"preClose":5.84,"latestTime":"19:30 EDT","volume":218,"amount":1273.12,"timestamp":1788564603533,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.05797101449275368,"floatShares":11875400,"shares":37181979,"eps":-5.274373,"marketStatus":"休市中","change":0.32,"latestTime":"09-04 16:00:00 EDT","open":5.49,"high":5.865,"low":5.48,"amount":277253.3172032,"amplitude":0.069746,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.274373,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1788854400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":5.52,"postHourTrading":{"tag":"盘后","latestPrice":5.84,"preClose":5.84,"latestTime":"19:30 EDT","volume":218,"amount":1273.12,"timestamp":1788564603533,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8987283986154181,"impliedVol":2.8532,"impliedVolPercentile":0.877},"requestUrl":"/m/hq/s/ARMP","defaultTab":"news","newsList":[{"id":"1199559944","title":"Armata Pharmaceuticals公布2026年第二季度财务业绩并发布公司最新动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1199559944","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199559944?lang=zh_cn&edition=full","pubTime":"2026-08-13 04:06","pubTimestamp":1786565185,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals（股票代码：ARMP）今日正式披露了2026年第二季度的财务报告，并同步更新了公司近期的业务进展与战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARMP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189095639","title":"Armata Pharmaceuticals任命David House为新任首席财务官，7月17日生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1189095639","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189095639?lang=zh_cn&edition=full","pubTime":"2026-07-20 19:15","pubTimestamp":1784546114,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会的文件，Armata Pharmaceuticals, Inc.已任命David House为其新任首席财务官，该任命将于2026年7月17日正式生效。\n此次任命标志着公司管理层迎来了一位在财务领域拥有丰富经验的新成员。David House将负责领导公司的整体财务战略、规划及运营工作。\n公司此举旨在加强其财务管理团队，以支持未来的业务增长与发展计划。随着新首席财务官的上任，Armata Pharmaceuticals期待在财务管理和战略执行方面开启新的篇章。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARMP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194804557","title":"Armata Pharmaceuticals获FDA就AP-SA02治疗复杂性金黄色葡萄球菌菌血症的儿科初始研究计划达成一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1194804557","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194804557?lang=zh_cn&edition=full","pubTime":"2026-07-13 19:06","pubTimestamp":1783940809,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals, Inc. (ARMP) 已获得美国食品药品监督管理局（FDA）的认可，就其针对AP-SA02用于治疗复杂性金黄色葡萄球菌菌血症的初始儿科研究计划达成一致。这一进展标志着该候选疗法在应对儿童严重细菌感染方面迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145780268","title":"Armata Pharmaceuticals公司获Innoviva 2500万美元有担保信贷，2029年到期","url":"https://stock-news.laohu8.com/highlight/detail?id=1145780268","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145780268?lang=zh_cn&edition=full","pubTime":"2026-05-14 04:47","pubTimestamp":1778705237,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals公司近日与Innoviva达成一项有担保信贷协议，成功获得总额2500万美元的融资支持。该笔贷款期限设定至2029年，将为公司后续研发及运营提供关键资金保障。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARMP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170662396","title":"Armata Pharmaceuticals, Inc. 第一季度净亏损1.153亿美元，每股亏损3.16美元，去年同期亏损650万美元，每股亏损0.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1170662396","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170662396?lang=zh_cn&edition=full","pubTime":"2026-05-14 04:47","pubTimestamp":1778705235,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals, Inc. 公布的第一季度业绩显示，公司净亏损大幅扩大至1.153亿美元，折合每股亏损3.16美元。这一数字与去年同期的表现形成了鲜明对比，当时公司净亏损为650万美元，每股亏损0.18美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARMP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179252471","title":"Armata Pharmaceuticals任命生物制药商业高管Daniel B. Gilmer博士加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1179252471","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179252471?lang=zh_cn&edition=full","pubTime":"2026-04-27 19:02","pubTimestamp":1777287743,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals, Inc.宣布，资深生物制药商业执行官Daniel B. Gilmer博士已正式加入公司董事会。此次人事变动标志着该公司在强化商业战略布局方面迈出关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128719348","title":"Armata Pharmaceuticals推迟公布2025年第四季度及全年业绩并发布公司动态更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1128719348","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128719348?lang=zh_cn&edition=full","pubTime":"2026-03-19 19:02","pubTimestamp":1773918143,"startTime":"0","endTime":"0","summary":"Armata Pharmaceuticals, Inc.宣布将延迟发布原定于近期公布的2025财年第四季度及全年财务业绩报告。此次延期同时伴随着公司最新运营动态的披露，管理层表示将择期另行公布具体业绩数据及战略规划进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618390381","title":"Armata Pharmaceuticals, Inc.盘中异动 急速下挫5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618390381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2618390381?lang=zh_cn&edition=full","pubTime":"2026-03-11 22:46","pubTimestamp":1773240409,"startTime":"0","endTime":"0","summary":"北京时间2026年03月11日22时46分，Armata Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.10%。Armata Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Armata Pharmaceuticals, Inc.公司简介：Armata Pharmaceuticals Inc 是一家病原体特异性噬菌体疗法的开发商，利用其专有的噬菌体技术来治疗抗生素耐药性和难以治疗的细菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311224649a6b86f26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311224649a6b86f26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARMP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516063206","title":"Armata Pharmaceuticals, Inc.盘中异动 股价大涨8.30%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516063206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516063206?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:04","pubTimestamp":1741014241,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时04分，Armata Pharmaceuticals, Inc.股票出现异动，股价快速拉升8.30%。Armata Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Armata Pharmaceuticals, Inc.公司简介：Armata Pharmaceuticals Inc 是一家病原体特异性噬菌体疗法的开发商，利用其专有的噬菌体技术来治疗抗生素耐药性和难以治疗的细菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230401a25d49cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230401a25d49cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513299904","title":"Armata Pharmaceuticals, Inc.盘中异动 股价大跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513299904","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513299904?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:02","pubTimestamp":1740150121,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时02分，Armata Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.47%。Armata Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Armata Pharmaceuticals, Inc.公司简介：Armata Pharmaceuticals Inc 是一家病原体特异性噬菌体疗法的开发商，利用其专有的噬菌体技术来治疗抗生素耐药性和难以治疗的细菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230201abd7b69c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230201abd7b69c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511691755","title":"Armata Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511691755","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511691755?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:14","pubTimestamp":1739546041,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时14分，Armata Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.03%。Armata Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Armata Pharmaceuticals, Inc.公司简介：Armata Pharmaceuticals Inc 是一家病原体特异性噬菌体疗法的开发商，利用其专有的噬菌体技术来治疗抗生素耐药性和难以治疗的细菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231401a2460b00&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231401a2460b00&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARMP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511757949","title":"Armata Pharmaceuticals, Inc.盘中异动 下午盘急速上涨6.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511757949","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511757949?lang=zh_cn&edition=full","pubTime":"2025-02-14 02:44","pubTimestamp":1739472290,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日02时44分，Armata Pharmaceuticals, Inc.股票出现波动，股价急速拉升6.67%。Armata Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。Armata Pharmaceuticals, Inc.公司简介：Armata Pharmaceuticals Inc 是一家病原体特异性噬菌体疗法的开发商，利用其专有的噬菌体技术来治疗抗生素耐药性和难以治疗的细菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214024450a244dd7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214024450a244dd7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510862334","title":"Armata Pharmaceuticals, Inc.盘中异动 股价大涨5.23%报2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510862334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510862334?lang=zh_cn&edition=full","pubTime":"2025-02-11 00:08","pubTimestamp":1739203708,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日00时08分，Armata Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.23%。Armata Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Armata Pharmaceuticals, Inc.公司简介：Armata Pharmaceuticals Inc 是一家病原体特异性噬菌体疗法的开发商，利用其专有的噬菌体技术来治疗抗生素耐药性和难以治疗的细菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211000828961e1332&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211000828961e1332&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506117255","title":"Armata Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506117255","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506117255?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:32","pubTimestamp":1738074752,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时32分，Armata Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.45%。Armata Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Armata Pharmaceuticals, Inc.公司简介：Armata Pharmaceuticals Inc 是一家病原体特异性噬菌体疗法的开发商，利用其专有的噬菌体技术来治疗抗生素耐药性和难以治疗的细菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822323298756b9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012822323298756b9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506588820","title":"Armata Pharmaceuticals, Inc.盘中异动 股价大跌5.12%报2.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506588820","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506588820?lang=zh_cn&edition=full","pubTime":"2025-01-28 01:34","pubTimestamp":1737999297,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日01时34分，Armata Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.12%。Armata Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.23%。Armata Pharmaceuticals, Inc.公司简介：Armata Pharmaceuticals Inc 是一家病原体特异性噬菌体疗法的开发商，利用其专有的噬菌体技术来治疗抗生素耐药性和难以治疗的细菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280134579874cbdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280134579874cbdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARMP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505684043","title":"Armata Pharmaceuticals, Inc.盘中异动 股价大涨6.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505684043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505684043?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:19","pubTimestamp":1737649165,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时19分，Armata Pharmaceuticals, Inc.股票出现异动，股价大幅上涨6.84%。Armata Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Exicure, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Dogwood Therapeutics, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为3544.69%、1689.70%、651.25%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Jupiter Neurosciences, Inc.，振幅分别为186.07%、64.29%、55.57%。Armata Pharmaceuticals, Inc.公司简介：Armata Pharmaceuticals Inc 是一家病原体特异性噬菌体疗法的开发商，利用其专有的噬菌体技术来治疗抗生素耐药性和难以治疗的细菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001925abb61192&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001925abb61192&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505627902","title":"Armata Pharmaceuticals, Inc.盘中异动 早盘大幅拉升8.26%报2.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505627902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505627902?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:37","pubTimestamp":1737470229,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时37分，Armata Pharmaceuticals, Inc.股票出现异动，股价大幅上涨8.26%。Armata Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.08%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Replimune Group, Inc.、Dogwood Therapeutics, Inc.涨幅较大，Dogwood Therapeutics, Inc.、Dermata Therapeutics, Inc.、Aditxt, Inc.较为活跃，换手率分别为565.99%、162.73%、44.75%，振幅较大的相关个股有Allakos Inc.、Dominari Holdings Inc.、Equillium, Inc.，振幅分别为112.09%、108.29%、107.00%。Armata Pharmaceuticals, Inc.公司简介：Armata Pharmaceuticals Inc 是一家病原体特异性噬菌体疗法的开发商，利用其专有的噬菌体技术来治疗抗生素耐药性和难以治疗的细菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223709960bba46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223709960bba46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARMP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504333167","title":"Armata Pharmaceuticals, Inc.盘中异动 股价大涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504333167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504333167?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:54","pubTimestamp":1737125641,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时54分，Armata Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.39%。Armata Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Armata Pharmaceuticals, Inc.公司简介：Armata Pharmaceuticals Inc 是一家病原体特异性噬菌体疗法的开发商，利用其专有的噬菌体技术来治疗抗生素耐药性和难以治疗的细菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117225401abaeb5ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117225401abaeb5ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503539569","title":"Armata Pharmaceuticals, Inc.盘中异动 急速下跌6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503539569","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503539569?lang=zh_cn&edition=full","pubTime":"2025-01-14 02:04","pubTimestamp":1736791461,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日02时04分，Armata Pharmaceuticals, Inc.股票出现波动，股价急速下挫6.19%。Armata Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Armata Pharmaceuticals, Inc.公司简介：Armata Pharmaceuticals Inc 是一家病原体特异性噬菌体疗法的开发商，利用其专有的噬菌体技术来治疗抗生素耐药性和难以治疗的细菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011402042196027517&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011402042196027517&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502789251","title":"Armata Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.51%报2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502789251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502789251?lang=zh_cn&edition=full","pubTime":"2025-01-11 00:56","pubTimestamp":1736528207,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日00时56分，Armata Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.51%。Armata Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.75%。Armata Pharmaceuticals, Inc.公司简介：Armata Pharmaceuticals Inc 是一家病原体特异性噬菌体疗法的开发商，利用其专有的噬菌体技术来治疗抗生素耐药性和难以治疗的细菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011100564798620711&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011100564798620711&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARMP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.armatapharma.com","stockEarnings":[{"period":"1week","weight":0.0875},{"period":"1month","weight":0.2426},{"period":"3month","weight":-0.2213},{"period":"6month","weight":-0.4491},{"period":"1year","weight":0.9663},{"period":"ytd","weight":-0.0701}],"compareEarnings":[{"period":"1week","weight":0.0011},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0443},{"period":"6month","weight":0.1455},{"period":"1year","weight":0.1865},{"period":"ytd","weight":0.1294}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Armata Pharmaceuticals, Inc.于1989年3月根据华盛顿州法律，作为了Immunex公司的全资子公司成立，并于1992年作为一个独立的有针对性的遗传学公司开始运作。该公司是一家处于后期临床阶段的生物技术公司，专注于开发高纯度、病原体特异性的噬菌体疗法，用于治疗抗生素耐药和难治性细菌感染。它已完成多项2期临床试验，并正在推进针对慢性肺部及全身性细菌感染的候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.818182,"avgChangeRate":0.238771},{"month":2,"riseRate":0.636364,"avgChangeRate":0.090756},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.078767},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.086781},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.0945},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.053209},{"month":7,"riseRate":0.454545,"avgChangeRate":0.093383},{"month":8,"riseRate":0.454545,"avgChangeRate":0.060565},{"month":9,"riseRate":0.5,"avgChangeRate":-0.040949},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.021708},{"month":11,"riseRate":0.454545,"avgChangeRate":0.010332},{"month":12,"riseRate":0.181818,"avgChangeRate":-0.108156}],"exchange":"AMEX","name":"Armata Pharmaceuticals, Inc.","nameEN":"Armata Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Armata Pharmaceuticals, Inc.(ARMP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Armata Pharmaceuticals, Inc.(ARMP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Armata Pharmaceuticals, Inc.,ARMP,Armata Pharmaceuticals, Inc.股票,Armata Pharmaceuticals, Inc.股票老虎,Armata Pharmaceuticals, Inc.股票老虎国际,Armata Pharmaceuticals, Inc.行情,Armata Pharmaceuticals, Inc.股票行情,Armata Pharmaceuticals, Inc.股价,Armata Pharmaceuticals, Inc.股市,Armata Pharmaceuticals, Inc.股票价格,Armata Pharmaceuticals, Inc.股票交易,Armata Pharmaceuticals, Inc.股票购买,Armata Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Armata Pharmaceuticals, Inc.(ARMP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Armata Pharmaceuticals, Inc.(ARMP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}